Intervention

PSA test

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common conditions6

Lead sponsors shown4

Clinical trials

4 shown

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen TestNCT05629494 · 2022-09-27

RECRUITING

Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance ImagingNCT04993508 · 2026-04-01

NOT_YET_RECRUITING

Sequential bpMRI for Suspicious Prostate LesionsNCT07332832 · 2026-02-01

NOT_YET_RECRUITING

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerNCT00261456 · 2005-03-01

ACTIVE_NOT_RECRUITING

Common conditions

Prostate Cancer4 BRCA Mutation1 Genetic Predisposition to Disease1 Mismatch Repair Gene Mutation1 Prostate Inflammation1 PSA1

Leading sponsors

Albany Medical College 1 Heinrich-Heine University, Duesseldorf 1 Institute of Cancer Research, United Kingdom 1 Peking University First Hospital 1

Trial status mix

NOT_YET_RECRUITING2

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.